Acute respiratory distress syndrome after kidney transplantation: Epidemiology, risk factors, and outcomes

Critical Care Medicine

Volumn 31, Issue 5, 2003, Pages 1325-1330

  Shorr, A F ^a   Abbott, K C ^a   Agadoa, L Y ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Acute respiratory distress syndrome; Epidemiology; Kidney; Mortality; Outcome; Risk transplant

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; DISEASE COURSE; FEMALE; GRAFT FAILURE; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES;

ADULT; ANALYSIS OF VARIANCE; ANTILYMPHOCYTE SERUM; COMORBIDITY; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT DISCHARGE; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 0038243640     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000053645.38356.A6     Document Type: Article

References (26)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
2. Brower RD, Ware LB, Berthiaume Y, et al: Treatment of ARDS. Chest 2001; 120:1247-1267
3. Milberg JA, Davis DR, Steinberg KH, et al: Improved survival of patients with acute respiratory distress syndrome 1983-1993. JAMA 1995; 273:306-309
4. Hudson LD, Milberg JA, Anardi D, et al: Clinical risks for the development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:293-301
5. Zilberg MD, Epstein SK: Acute lung injury in the medical intensive care unit: Comorbid conditions, age, etiologies and hospital outcome. Am J Respir Crit Care Med 1998; 157:1159-1164
6. Den NC, Amend WC, Matthay MA: Adult respiratory distress syndrome related to antilymphocyte globulin therapy. Chest 1987; 91:619-620
7. Gross DC, Saschi TM, Burch MK, et al: Acute respiratory failure and pulmonary fibrosis secondary to administration of mycophenolate mofetil. Transplantation 1997; 64:1607-1609
8. Walter GD, Gualtiere RJ: Antithymocyte globulin induced acute respiratory distress syndrome. Arch Intern Med 1998; 198:1380
9. Levy MF, Greene L, Ramsy MAE, et al: Readmission to the intensive care unit after liver transplantation. Crit Care Med 2001; 29:18-24
10. Data available at www.patients.unos.org. Accessed on February 16, 2002
11. Eggers P: Comparison of treatment costs between dialysis and transplantation. Semin Nephrol 1992; 12:284-289
12. Harikand S, Johnson CP, Bresnahan BA, et al: Improved graft survival after renal transplantation in the United States 1988 to 1996. N Engl J Med 2000; 342:605-612
13. Ramanathan V, Goral S, Hederman JH: Renal transplantation. Semin Nephrol 2001; 21:213-219
14. Thomsen GE, Morris AH: Incidence of the adult respiratory distress syndrome in the state of Utah. Am J Respir Crit Care Med 1995; 152:965-971
15. Sadaghdar H, Chelluri L, Bowles SA, et al: Outcome of renal transplant recipients in the intensive care unit. Chest 1995; 107:1402-1405
16. Kogan A, Singer P, Cohen J, et al: Readmission to the intensive care unit following liver and kidney transplantation: A 50 month study. Transplant Proc 1999; 31:1892-1893
17. Webster NR, Cohen AT, Nunn JF: Adult respiratory distress syndrome - How many cases in the UK? Anaesthesia 1998; 43:923-926
18. Lur OR, Anthone R, Kalsion M, et al: Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am J Respir Crit Care Med 1999; 159:1849-1861
19. Bacigalupo A, Lamparelli T, Bruzzi P, et al: Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo. Blood 2001; 98:2942-2947
20. Costanzo-Nordin MR: Cardiopulmonary effects of OKT-3: Determinants of hypotension, pulmonary edema, and cardiac dysfunction. Transplant Proc 1993; 25(Suppl 1):21-24
21. Meier-Kriesche H, Arndorfer JA, Kaplan B: Association of antibody induction with short- and long-term cause specific mortality in renal transplant recipients. J Am Soc Nephrol 2002; 13:769-772
22. Walsh RF, Springate JE, Spivak BS, et al: Cyclosporine and adult respiratory distress syndrome. Transplantation 1998; 5:776-777
23. Piaggio G, Podesta M, Pitto A, et al: Comparable TNF-alpha, IFN-gamma and GM-CSF production by purified normal bone marrow CD3 cells in response to horse anti-lymphocyte and rabbit antithymocyte globulin. Eur J Haematol 1998; 60:240-244
24. Barbano GC, Schenone A, Roncella S, et al: Anti-lymphocyte globulin stimulates normal human T cells to proliferate and to release lymphokines in vitro. A study at the clonal level. Blood 1988; 72:956-963
25. Sindhi R, Stratta RJ, Taylor RJ, et al: Increased risk of pulmonary edema in diabetic patients undergoing preemptive pancreas transplantation with kidney transplantation-3 induction. Transplant Proc 1998; 27:3016-3017
26. Maillard N, Foucher P, Caillot D, et al: Transient pulmonary infiltrates during treatment with anti-thymocyte globulin. Respiration 1999; 66:279-282